These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 19166434

  • 1. A comparison of glycaemic variability in CSII vs. MDI treated type 1 diabetic patients using CGMS.
    Simon B, Treat V, Marco C, Rosenberg D, Joseph J, Hipszer B, Li Y, Chervoneva I, Padron-Massara L, Jabbour S.
    Int J Clin Pract; 2008 Dec; 62(12):1858-63. PubMed ID: 19166434
    [Abstract] [Full Text] [Related]

  • 2. In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine.
    Bruttomesso D, Crazzolara D, Maran A, Costa S, Dal Pos M, Girelli A, Lepore G, Aragona M, Iori E, Valentini U, Del Prato S, Tiengo A, Buhr A, Trevisan R, Baritussio A.
    Diabet Med; 2008 Mar; 25(3):326-32. PubMed ID: 18307459
    [Abstract] [Full Text] [Related]

  • 3. Safety of various methods of intensive insulin therapy in hospital condition assessed by hypoglycaemic episodes detected with the use of continuous glucose monitoring system.
    Mozdzan M, Ruxer J, Loba J, Siejka A, Markuszewski L.
    Adv Med Sci; 2006 Mar; 51():133-6. PubMed ID: 17357293
    [Abstract] [Full Text] [Related]

  • 4. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues.
    Torres I, Ortego J, Valencia I, García-Palacios MV, Aguilar-Diosdado M.
    Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):378-85. PubMed ID: 19629931
    [Abstract] [Full Text] [Related]

  • 5. Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up.
    Sulli N, Shashaj B.
    Diabet Med; 2006 Aug; 23(8):900-6. PubMed ID: 16911629
    [Abstract] [Full Text] [Related]

  • 6. Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion.
    Pickup JC, Sutton AJ.
    Diabet Med; 2008 Jul; 25(7):765-74. PubMed ID: 18644063
    [Abstract] [Full Text] [Related]

  • 7. The importance of anti-insulin antibody in patients with type 1 diabetes mellitus treated with continuous subcutaneous insulin infusion or multiple daily insulin injections therapy.
    Sahin SB, Cetinkalp S, Ozgen AG, Saygili F, Yilmaz C.
    Acta Diabetol; 2010 Dec; 47(4):325-30. PubMed ID: 20842389
    [Abstract] [Full Text] [Related]

  • 8. Substitution of night-time continuous subcutaneous insulin infusion therapy for bedtime NPH insulin in a multiple injection regimen improves counterregulatory hormonal responses and warning symptoms of hypoglycaemia in IDDM.
    Kanc K, Janssen MM, Keulen ET, Jacobs MA, Popp-Snijders C, Snoek FJ, Heine RJ.
    Diabetologia; 1998 Mar; 41(3):322-9. PubMed ID: 9541173
    [Abstract] [Full Text] [Related]

  • 9. A randomized pilot study in Type 1 diabetes complicated by severe hypoglycaemia, comparing rigorous hypoglycaemia avoidance with insulin analogue therapy, CSII or education alone.
    Thomas RM, Aldibbiat A, Griffin W, Cox MA, Leech NJ, Shaw JA.
    Diabet Med; 2007 Jul; 24(7):778-83. PubMed ID: 17535290
    [Abstract] [Full Text] [Related]

  • 10. Quality of life and treatment satisfaction in adults with Type 1 diabetes: a comparison between continuous subcutaneous insulin infusion and multiple daily injections.
    EQuality1 Study Group--Evaluation of QUALITY of Life and Costs in Diabetes Type 1, Nicolucci A, Maione A, Franciosi M, Amoretti R, Busetto E, Capani F, Bruttomesso D, Di Bartolo P, Girelli A, Leonetti F, Morviducci L, Ponzi P, Vitacolonna E.
    Diabet Med; 2008 Feb; 25(2):213-20. PubMed ID: 18201210
    [Abstract] [Full Text] [Related]

  • 11. Glucose profiles in a type 1 diabetic patient successively treated with CSII using regular insulin, lispro and an implantable insulin pump.
    Catargi B, Breilh D, Roger P, Tabarin A.
    Diabetes Metab; 2000 May; 26(3):210-4. PubMed ID: 10880895
    [Abstract] [Full Text] [Related]

  • 12. Comparison between a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) using continuous glucose monitoring in metabolically optimized type 1 diabetes patients: A randomized open-labelled parallel study.
    Ruiz-de-Adana MS, Dominguez-Lopez ME, Gonzalez-Molero I, Machado A, Martin V, Cardona I, de-la-Higuera M, Tapia MJ, Soriguer F, Anarte MT, Rojo-Martínez G.
    Med Clin (Barc); 2016 Mar 18; 146(6):239-46. PubMed ID: 26656958
    [Abstract] [Full Text] [Related]

  • 13. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
    Bode BW.
    Clin Ther; 2007 Mar 18; 29 Suppl D():S135-44. PubMed ID: 18191065
    [Abstract] [Full Text] [Related]

  • 14. Continuous subcutaneous insulin infusion benefits quality of life in preschool-age children with type 1 diabetes mellitus.
    Opipari-Arrigan L, Fredericks EM, Burkhart N, Dale L, Hodge M, Foster C.
    Pediatr Diabetes; 2007 Dec 18; 8(6):377-83. PubMed ID: 18036064
    [Abstract] [Full Text] [Related]

  • 15. Continuous subcutaneous insulin infusion is more effective than multiple daily insulin injections in preventing albumin excretion rate increase in Type 1 diabetic patients.
    Lepore G, Bruttomesso D, Bonomo M, Dodesini AR, Costa S, Meneghini E, Corsi A, Nosari I, Trevisan R.
    Diabet Med; 2009 Jun 18; 26(6):602-8. PubMed ID: 19538235
    [Abstract] [Full Text] [Related]

  • 16. Pregnancy outcome and glycemic control in women with type 1 diabetes: a retrospective comparison between CSII and MDI treatment.
    Talaviya PA, Saboo BD, Joshi SR, Padhiyar JN, Chandarana HK, Shah SJ, Vyas CK, Shah AN.
    Diabetes Metab Syndr; 2013 Jun 18; 7(2):68-71. PubMed ID: 23680243
    [Abstract] [Full Text] [Related]

  • 17. Outcome of pregnancy in women with type 1 diabetes intensively treated with continuous subcutaneous insulin infusion or conventional therapy. A case-control study.
    Giménez M, Conget I, Nicolau J, Pericot A, Levy I.
    Acta Diabetol; 2007 Mar 18; 44(1):34-7. PubMed ID: 17357884
    [Abstract] [Full Text] [Related]

  • 18. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment: a randomized study. The Study Group for the Development of Pump Therapy in Diabetes.
    Hanaire-Broutin H, Melki V, Bessières-Lacombe S, Tauber JP.
    Diabetes Care; 2000 Sep 18; 23(9):1232-5. PubMed ID: 10977011
    [Abstract] [Full Text] [Related]

  • 19. A 2-way cross-over, open-labeled trial to compare efficacy and safety of insulin Aspart and Novolin R delivered with CSII in 21 Chinese diabetic patients.
    Bi YF, Zhao LB, Li XY, Wang WQ, Sun SY, Chen YH, Hong J, Su TW, Liu JM, Ning G.
    Chin Med J (Engl); 2007 Oct 05; 120(19):1700-3. PubMed ID: 17935674
    [Abstract] [Full Text] [Related]

  • 20. Children and adolescents on intensive insulin therapy maintain postprandial glycaemic control without precise carbohydrate counting.
    Smart CE, Ross K, Edge JA, Collins CE, Colyvas K, King BR.
    Diabet Med; 2009 Mar 05; 26(3):279-85. PubMed ID: 19317823
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.